Cargando…
Intra-arterial chemotherapy in retinoblastoma – A paradigm change
Intra-arterial chemotherapy (IAC), also known as superselective ophthalmic artery chemotherapy or chemosurgery, is currently widely accepted as one of the primary treatment modalities for intraocular retinoblastoma worldwide. Following the introduction of the technique in 1998, IAC has evolved over...
Autores principales: | Manjandavida, Fairooz P, Stathopoulos, Christina, Zhang, Jing, Honavar, Santhosh G, Shields, Carol L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552585/ https://www.ncbi.nlm.nih.gov/pubmed/31124482 http://dx.doi.org/10.4103/ijo.IJO_866_19 |
Ejemplares similares
-
The role of intravitreal chemotherapy for retinoblastoma
por: Manjandavida, Fairooz P, et al.
Publicado: (2015) -
Orbital retinoblastoma: An update
por: Honavar, Santosh G, et al.
Publicado: (2017) -
In-utero ultrasonography detection of fetal retinoblastoma and neonatal selective ophthalmic artery chemotherapy
por: Manjandavida, Fairooz P, et al.
Publicado: (2019) -
Update on Intra-Arterial Chemotherapy for Retinoblastoma
por: Zanaty, Mario, et al.
Publicado: (2014) -
Erratum: Intra-arterial chemotherapy in retinoblastoma – A paradigm change
Publicado: (2019)